Gc protein-derived macrophage-activating factor (GcMAF) stimulates cAMP formation in human mononuclear cells and inhibits angiogenesis in chick embryo chorionallantoic membrane assay
- 276 Downloads
The effects of Gc protein-derived macrophage-activating factor (GcMAF) have been studied in cancer and other conditions where angiogenesis is deregulated. In this study, we demonstrate for the first time that the mitogenic response of human peripheral blood mononuclear cells (PBMCs) to GcMAF was associated with 3′-5′-cyclic adenosine monophosphate (cAMP) formation. The effect was dose dependent, and maximal stimulation was achieved using 0.1 ng/ml. Heparin inhibited the stimulatory effect of GcMAF on PBMCs. In addition, we demonstrate that GcMAF (1 ng/ml) inhibited prostaglandin E1- and human breast cancer cell-stimulated angiogenesis in chick embryo chorionallantoic membrane (CAM) assay. Finally, we tested different GcMAF preparations on CAM, and the assay proved to be a reliable, reproducible and inexpensive method to determine the relative potencies of different preparations and their stability; we observed that storage at room temperature for 15 days decreased GcMAF potency by about 50%. These data could prove useful for upcoming clinical trials on GcMAF.
KeywordsGcMAF cAMP Angiogenesis Peripheral blood human mononuclear cells
This research project has been subsidized by the University of Firenze (Progetti di Ricerca di Ateneo, ex 60%) and by the Italian Ministry of Health (Progetto Strategico “La Medicina di genere come obiettivo strategico per la sanità pubblica: l’appropriatezza della cura per la tutela della salute della donna”). We are indebted with Prof. N. Yamamoto for providing GcMAF and inspiring discussion.
- 1.Yamamoto N, Naraparaju VR (1997) Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor. Cancer Res 47:2187–2192Google Scholar
- 7.Nonaka K, Onizuka S, Ishibashi H, Uto Y, Hori H, Nakayama T, Matsuura N, Kanematsu T, Fujioka H (2010) Vitamin D binding protein-macrophage activating factor inhibits HCC in SCID mice. J Surg Res Sep 18 [Epub ahead of print]Google Scholar
- 9.W81XWH-04-1-0010. Treatment of prostate cancer with a DBP-MAF-vitamin D complex to target angiogenesis and tumorigenesis. Michael W. Fannon, Ph.D. University of Kentucky Research Foundation Lexington, Kentucky 40506-0057. U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012. (Approved for Public Release; Distribution Unlimited)Google Scholar
- 22.Lulli M, Di Gesualdo F, Witort E et al. (2010) Cell death: physiopathological and therapeutic implications. Cell Death Dis. doi: 10.1038/cddis.2010.8
- 23.Takahashi HK, Liu K, Wake H, Mori S, Zhang J, Liu R, Yoshino T, Nishibori M (2009) Prostaglandin E2 inhibits advanced glycation end product-induced adhesion molecule expression, cytokine production, and lymphocyte proliferation in human peripheral blood mononuclear cells. J Pharmacol Exp Ther 331:656–670PubMedCrossRefGoogle Scholar
- 37.http://www.gcmaf.eu/info/. Accessed 08 October 2010
- 38.http://immunemedicine.com/available-therapies/gcmaf/. Accessed 08 October 2010
- 39.http://www.gcmaf.nl. Accessed 08 October 2010